Yüklüyor......
Effectiveness of Ledipasvir/Sofosbuvir with/without Ribavarin in Liver Transplant Recipients with Hepatitis C
Background and Aims: Recurrent infection of hepatitis C virus (HCV) in liver transplant (LT) recipients is universal and associated with significant morbidity and mortality. Methods: We retrospectively evaluated the safety and efficacy of ledipasvir/sofosbuvir with and without ribavirin in LT recipi...
Kaydedildi:
| Yayımlandı: | J Clin Transl Hepatol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
XIA & HE Publishing Inc.
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5472930/ https://ncbi.nlm.nih.gov/pubmed/28660147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14218/JCTH.2016.00070 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|